The stock gained 5.22 per cent to Rs 204.30 on BSE.
At NSE, shares of the company went up 5.27 per cent to Rs 204.50.
The company has been granted "one product patent from Europe and one product patent from Israel corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neuro-degenerative diseases," it said in a BSE filing today.
The patents are valid through 2030 and 2029 respectively, the company added.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)